2-Amino-6-((p-tolylthio)methyl)pyrimidin-4-ol

Catalog No.: 
ACOLDF941
CAS No.: 
1114596-99-4
Molecular Formula: 
C12H13N3OS
Molecular Weight: 
247.32
2-Amino-6-((p-tolylthio)methyl)pyrimidin-4-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$161.00InquiryInquiry
1g95%$402.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Amino-6-((p-tolylthio)methyl)pyrimidin-4-ol
IUPAC Name2-amino-6-((p-tolylthio)methyl)pyrimidin-4(3H)-one
Molecular FormulaC12H13N3OS
Molecular Weight247.32
SMILESOC1=NC(N)=NC(CSC2=CC=C(C)C=C2)=C1
InChI KeyITRVQJAEGVOEDT-UHFFFAOYSA-N
Synonym2-amino-6-{[(4-methylphenyl)thio]methyl}pyrimidin-4-ol;4(3H)-Pyrimidinone, 2-amino-6-[[(4-methylphenyl)thio]methyl]-;2-Amino-6-((p-tolylthio)methyl)pyrimidin-4(3h)-one
CAS No.1114596-99-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACOLDF941 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOLDF941 route product structure diagram
    ACOLDF9411114596-99-4
Inquiry

2. ACOLDF941 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOLDF941 route product structure diagram
    ACOLDF9411114596-99-4
Inquiry

3. ACOLDF941 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOLDF941 route product structure diagram
    ACOLDF9411114596-99-4
Inquiry

Comments (0)